ETR:RHK RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis → The only AI company you should be looking at (From Behind the Markets) (Ad) Free RHK Stock Alerts €11.20 -0.10 (-0.88%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range€11.10▼€11.2050-Day Range€9.60▼€12.3052-Week Range€9.50▼€13.70Volume1,389 shsAverage Volume43,281 shsMarket Capitalization$749.73 millionP/E Ratio22.86Dividend Yield1.34%Price TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get RHÖN-KLINIKUM Aktiengesellschaft alerts: Email Address Ad Crypto 101 MediaAltcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) About RHÖN-KLINIKUM Aktiengesellschaft Stock (ETR:RHK)RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.Read More RHK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RHK Stock News HeadlinesMay 12, 2022 | finanznachrichten.deZukunft des UKGM: Rhön-Klinikum stellt Einigung infrageMarch 25, 2022 | finanznachrichten.deRhön-Klinikum kommt gut durchs Corona-Jahr 2021March 19, 2024 | Paradigm Press (Ad)8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: March 25, 2022 | uk.finance.yahoo.comRHÖN-KLINIKUM AG looks back on successful financial year 2021February 19, 2022 | finanznachrichten.deWarum Technik und Medizin gut zusammenpassen - RHÖN fördert praxisorientierte Studien- und BerufsorientierungFebruary 19, 2022 | finanznachrichten.deRHÖN-KLINIKUM Campus Bad Neustadt ist TAVI-ZentrumSee More Headlines Receive RHK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolETR:RHK CUSIPN/A CIKN/A Webwww.rhoen-klinikum-ag.com Phone+49-9-771650FaxN/AEmployees18,158Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.49 Trailing P/E Ratio23.06 Forward P/E Ratio42.02 P/E Growth26.77Net Income$31.92 million Net Margins1.87% Pretax MarginN/A Return on Equity2.62% Return on Assets1.08% Debt Debt-to-Equity Ratio11.89 Current Ratio2.28 Quick Ratio2.12 Sales & Book Value Annual Sales$1.71 billion Price / Sales0.44 Cash Flow€4.11 per share Price / Cash Flow2.75 Book Value€19.14 per share Price / Book0.59Miscellaneous Outstanding Shares66,940,000Free FloatN/AMarket Cap$756.42 million OptionableNot Optionable Beta-0.01 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Tobias Kaltenbach (Age 64)Chairman of Management Board Comp: $547kDr. Stefan Stranz (Age 47)CFO & Member of Management Board Comp: $668kDr. Gunther Karl Weiß M.Sc. (Age 56)COO & Member of Management Board Comp: $708kJulian SchmittHead of Investor Relations & TreasuryMr. Eugen MünchChief RepresentativeKey CompetitorsBiotest AktiengesellschaftETR:BIOStratecETR:SBSDrägerwerk AG & Co. KGaAETR:DRW3CompuGroup Medical SE & Co. KGaAETR:COPShop Apotheke EuropeETR:SAEView All Competitors RHK Stock Analysis - Frequently Asked Questions How have RHK shares performed in 2024? RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at €10.00 at the beginning of 2024. Since then, RHK shares have increased by 12.0% and is now trading at €11.20. View the best growth stocks for 2024 here. Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock? RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) pays an annual dividend of €0.15 per share and currently has a dividend yield of 1.33%. The dividend payout ratio is 30.61%. This payout ratio is at a healthy, sustainable level, below 75%. What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some companies that other RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), iShares Silver Trust (SLV), Walt Disney (DIS), Alamos Gold (AGI), Warriedar Resources (AWV), Bayerische Motoren Werke Aktiengesellschaft (BMW), Anheuser-Busch InBev SA/NV (BUD), Cognex (CGNX), Canadian National Railway (CNI) and Warner Bros. Discovery (DISCK). This page (ETR:RHK) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RHÖN-KLINIKUM Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.